Skip to main content
E

Elixionbiotech

This company develops novel therapeutics by integrating quantum physics, causal biology, and multi-omics data with native-AI platforms. Their approach aims to accelerate drug discovery and enhance therapeutic precision for patient benefit. The core value lies in leveraging advanced computational and biological methods to create next-generation pharmaceutical candidates.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

  • This company develops novel therapeutics by integrating quantum physics, causal biology, and multi-omics data with native-AI methodologies. Their approach aims to accelerate drug discovery and increase therapeutic precision for patient benefit. The resulting pipeline focuses on delivering advanced pharmaceutical solutions through advanced computational and biological modeling.
This profile is AI-generated and may contain inaccuracies.